I am watching the soft tissue repair revolution heating up fast.
Rotator cuff tears alone affect millions, with re-tear rates as high as 20-90% depending on tear size—yet too many surgeons are stuck with rigid anchors and patches that prioritize fixation over true healing.
Patients deserve better: implants that adapt intraoperatively, promote biological integration, and slash the need for revision surgeries.
When a patient’s orthopedist warns of a failed repair and another operation, savvy folks start hunting for tech that actually mends the tendon-bone interface without compromising blood flow or bone integrity.
“I want my shoulder back, but without the risk of it all unraveling in a year.”
Below is the story of AevumEd, a medtech powerhouse pioneering adjustable suture anchors and AI-guided scaffolds to transform tendon regeneration, and gain actionable wisdom from Dr. Saif Khalil on engineering devices that heal for the long haul.
What Really Separates Breakthrough Implants From Commodity Ones?(Hint: It’s the Process—and Surgeon Buy-In.)
Dr. Saif Khalil, PhD, founder and CEO of AevumEd, shares his best advice for building medtech that doesn’t just fix problems but prevents them...
